DNMT3A and acute lymphoblastic leukemia: Detected in the ALL borderland cohort were genes involved in epigenetic regulation at the next level of clinical significance, including DNMT3A, TET2, and WT1. These genes were observed harboring variants with mutational significance in Tier X and Tier 3, respectively (Figure 2).